CS Mckee LP lessened its holdings in Humana Inc (NYSE:HUM) by 4.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 72,510 shares of the insurance provider’s stock after selling 3,050 shares during the quarter. CS Mckee LP owned approximately 0.05% of Humana worth $17,988,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also modified their holdings of the company. Cadence Capital Management LLC boosted its stake in shares of Humana by 3.6% in the 3rd quarter. Cadence Capital Management LLC now owns 5,887 shares of the insurance provider’s stock valued at $1,434,000 after purchasing an additional 205 shares during the last quarter. Daiwa SB Investments Ltd. boosted its stake in shares of Humana by 44.9% in the 4th quarter. Daiwa SB Investments Ltd. now owns 710 shares of the insurance provider’s stock valued at $176,000 after purchasing an additional 220 shares during the last quarter. HL Financial Services LLC boosted its stake in shares of Humana by 2.1% in the 4th quarter. HL Financial Services LLC now owns 11,205 shares of the insurance provider’s stock valued at $2,780,000 after purchasing an additional 230 shares during the last quarter. Mackenzie Financial Corp boosted its stake in shares of Humana by 3.6% in the 3rd quarter. Mackenzie Financial Corp now owns 6,642 shares of the insurance provider’s stock valued at $1,618,000 after purchasing an additional 232 shares during the last quarter. Finally, CIBC Asset Management Inc boosted its stake in shares of Humana by 1.5% in the 4th quarter. CIBC Asset Management Inc now owns 16,996 shares of the insurance provider’s stock valued at $4,216,000 after purchasing an additional 248 shares during the last quarter. 97.85% of the stock is currently owned by institutional investors.
Humana stock opened at $272.73 on Monday. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.48. Humana Inc has a one year low of $203.48 and a one year high of $293.35. The firm has a market cap of $37,550.56, a P/E ratio of 16.35, a price-to-earnings-growth ratio of 1.48 and a beta of 0.95.
Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, February 7th. The insurance provider reported $2.06 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.00 by $0.06. Humana had a net margin of 4.55% and a return on equity of 16.13%. The firm had revenue of $13.19 billion for the quarter, compared to analyst estimates of $13.14 billion. During the same quarter in the previous year, the firm posted $2.34 earnings per share. The business’s revenue was up 2.4% on a year-over-year basis. equities research analysts expect that Humana Inc will post 13.81 EPS for the current year.
Humana announced that its board has initiated a share buyback plan on Thursday, December 14th that allows the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization allows the insurance provider to purchase shares of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s leadership believes its shares are undervalued.
The business also recently declared a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Friday, March 30th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $2.00 dividend on an annualized basis and a yield of 0.73%. This is a positive change from Humana’s previous quarterly dividend of $0.40. Humana’s payout ratio is presently 9.59%.
In other Humana news, SVP Brian P. Leclaire sold 1,679 shares of Humana stock in a transaction that occurred on Thursday, December 21st. The shares were sold at an average price of $245.97, for a total value of $412,983.63. Following the transaction, the senior vice president now owns 9,888 shares of the company’s stock, valued at $2,432,151.36. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP Timothy S. Huval sold 1,382 shares of Humana stock in a transaction that occurred on Tuesday, December 19th. The shares were sold at an average price of $246.04, for a total transaction of $340,027.28. Following the completion of the sale, the vice president now owns 11,557 shares in the company, valued at $2,843,484.28. The disclosure for this sale can be found here. In the last ninety days, insiders sold 34,721 shares of company stock worth $9,421,229. Insiders own 0.60% of the company’s stock.
Several brokerages have recently issued reports on HUM. Zacks Investment Research lowered shares of Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, March 13th. Deutsche Bank lifted their price objective on shares of Humana from $259.00 to $270.00 and gave the stock a “hold” rating in a research note on Friday, February 9th. Cantor Fitzgerald reissued a “hold” rating and set a $250.00 price objective on shares of Humana in a research note on Wednesday, February 7th. Credit Suisse Group raised shares of Humana from a “neutral” rating to an “outperform” rating and reduced their price objective for the stock from $264.90 to $246.00 in a research note on Thursday, February 8th. Finally, Goldman Sachs assumed coverage on shares of Humana in a research note on Wednesday, January 3rd. They set a “buy” rating and a $305.00 price objective on the stock. Eight research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $270.47.
COPYRIGHT VIOLATION NOTICE: This piece of content was originally reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://ledgergazette.com/2018/03/19/cs-mckee-lp-sells-3050-shares-of-humana-inc-hum.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.